Caryn Peterson
Patrimonio netto: 59 906 $ in data 31/05/2026
Patrimonio netto: 59 906 $ in data 31/05/2026
Caryn L.
Peterson is the founder of DSC Associates LLC, which was founded in 2004.
She held the title of Managing Partner from 2004 to 2018.
Ms. Peterson's current job(s) include Chief Executive Officer at Alevium Pharmaceuticals, Inc. since 2009, Director at Aspen Neuroscience, Inc. since 2021, and Executive Vice President-Regulatory Affairs at Gossamer Bio, Inc. since 2018.
Ms. Peterson's former job(s) include Associate Director-Regulatory Affairs at Amylin Pharmaceuticals, Inc. from 1989 to 1997, Principal at Hybritech, Inc. from 1981 to 1989, Vice President-Regulatory Affairs at Syndax Pharmaceuticals, Inc. from 2008 to 2018, Vice President-Regulatory Affairs at OncoSec Medical, Inc., Vice President-Regulatory Affairs at Ascenta Therapeutics, Inc., and Vice President-Regulatory Affairs at FeRx, Inc. from 1997 to 2004.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
GOSSAMER BIO, INC. 0,05% | 19/03/2026 | 259.333 ( 0,05% ) | 59 906 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| GOSSAMER BIO, INC. | Consigliere Generale | 01/01/2018 |
Alevium Pharmaceuticals, Inc. | Amministratore Delegato | 01/06/2009 |
Aspen Neuroscience, Inc.
Aspen Neuroscience, Inc. Medical/Nursing ServicesHealth Services Provides neurological treatment services | Direttore/Membro del Consiglio | 23/06/2021 |
| Società | Posizione | Fine |
|---|---|---|
DSC Associates LLC | Fondatore | 01/01/2018 |
| SYNDAX PHARMACEUTICALS, INC. | Consigliere Generale | 01/01/2018 |
FeRx, Inc.
FeRx, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and distributes magnetic technology for the treatment of cancer | Consigliere Generale | 01/01/2004 |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Consigliere Generale | 01/01/1997 |
Hybritech, Inc.
Hybritech, Inc. Miscellaneous Commercial ServicesCommercial Services Provides prostate diagnostic testing services | Corporate Officer/Principal | 01/01/1989 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 10 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Hybritech, Inc.
Hybritech, Inc. Miscellaneous Commercial ServicesCommercial Services Provides prostate diagnostic testing services | Commercial Services |
Syndax Pharmaceuticals, Inc.
Syndax Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
OncoSec Medical, Inc.
OncoSec Medical, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel immunotherapeutic products for immuno-oncology treatment | Health Technology |
Ascenta Therapeutics, Inc.
Ascenta Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines for cancer | Health Technology |
FeRx, Inc.
FeRx, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and distributes magnetic technology for the treatment of cancer | Health Technology |
Alevium Pharmaceuticals, Inc. | |
DSC Associates LLC | |
Gossamer Bio, Inc.
Gossamer Bio, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing therapeutics for immunology, inflammation and oncology diseases | Health Technology |
Aspen Neuroscience, Inc.
Aspen Neuroscience, Inc. Medical/Nursing ServicesHealth Services Provides neurological treatment services | Health Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale